Qvents

Qvents

Discussion forum for Pharma Quality events, Regulatory Actions

Warning letters, 483s, Recalls, Import Alerts, Audit observations

In May 2023, Sun Pharma initiated recall of two lots of antidepressant drug Bupropion Hydrochloride 150mg Extended release tabletsdue to failure in dissolution during stability studies (Recall Event: 92289). The two lots were due for expiry in just about two months (In May 2023 and July 2023). Bupropion Hydrochloride is an antidepressant drug

Further in October 2023 (Recall Event ID: 93166) and November 2023 (Recall Event ID: 93472), Sun Pharma recalled two more lots of Bupripion Hydrochloride extended release tables which were expiring in December 2023, two months from recall.

Leave a Comment